How to Get Azelaic acid Online in Madrid
Need an Azelaic acid prescription in Madrid? Complete an online consultation with an EU-licensed doctor for 40 €, upload photos, and receive a REMPE electronic prescription if appropriate.

DIRECT ANTWOORD
Met een online consult kan een in de EU bevoegde arts uw situatie beoordelen en, indien passend, een recept afgeven dat in de hele EU geldig is.
Gemiddeld binnen 4 uur
Bij goedkeuring wordt het recept gemiddeld in minder dan 4 uur afgegeven.
In de EU bevoegde artsen
Elke situatie wordt beoordeeld door een bevoegde zorgprofessional.
Geldig in de hele EU
Goedgekeurde recepten zijn te gebruiken bij elke apotheek in de EU.
In dit artikel
You can get Azelaic acid online in Madrid through a direct medical consultation without waiting weeks for an in-person dermatology slot. An EU-licensed doctor reviews your skin history and submitted photos asynchronously to assess if topical azelaic acid 15% gel is clinically suitable. If approved, your official Spanish REMPE electronic prescription is issued in under 24 hours. The consultation fee is 40 €, doctors review within 24 hours, and your prescription can be presented at any EU pharmacy.
Over 50,000 patients have accessed clinical care through Hi-Doctor, maintaining a 4.8/5 Trustpilot rating across EU-wide telemedicine consultations.
How it works — get your consultation in 4 steps
Acquiring your dermatological assessment online in Madrid takes only a few minutes. Everything occurs asynchronously inside your secure account without video calls or clinic waiting rooms.
- Complete the medical questionnaire: Answer questions regarding your skin type, previous treatments, and current symptoms.
- Upload clear photographs: Provide high-resolution, well-lit photos of the affected facial areas for doctor review.
- Doctor assessment: An EU-licensed doctor evaluates your submission and clinical history within 24 hours.
- Receive your REMPE prescription: When clinically appropriate, the doctor issues a downloadable REMPE PDF to your account and notifies you by transactional email.

Who qualifies
Azelaic acid 15% gel (often prescribed under brand names such as Skinoren or Finacea) is indicated for specific dermatological conditions. Hi-Doctor's online dermatology pathway covers mild-to-moderate acne, rosacea, melasma, and skin ageing.

Adults residing in Madrid or anywhere in Spain qualify for an assessment if they experience inflammatory papules, pustules, comedones, or facial erythema. Because azelaic acid is non-photosensitising and has a favourable safety profile, it is frequently suitable for sensitive skin types, darker phototypes prone to post-inflammatory hyperpigmentation, and during pregnancy when other topicals are contraindicated.
Clinical exclusions: Hi-Doctor prescribes topical treatments only. Oral isotretinoin, oral antibiotics for acne, hormonal therapies, and severe, nodulocystic, or scarring acne are out of scope. Patients presenting severe or scarring symptoms are referred to in-person specialists.
What Azelaic-acid actually does
Azelaic acid is a naturally occurring dicarboxylic acid with dual antibacterial and comedolytic actions. It reduces the concentration of Cutibacterium acnes inside the follicular infundibulum and normalises keratinisation, preventing microcomedones from forming.
Unlike standard oral antibiotics, azelaic acid does not induce bacterial resistance. It also selectively inhibits hyperactive melanocytes by downregulating tyrosinase, making it exceptionally effective for post-acne pigmentation and melasma.
| Active Treatment | Primary Mechanism | Expected Timeline | Best Clinical Indication |
|---|---|---|---|
| Azelaic acid 15% gel | Comedolytic, anti-inflammatory, tyrosinase inhibitor | Early improvement at 4–8 weeks; full response at 12 weeks | Mild-moderate acne, rosacea, darker phototypes |
| Adapalene 0.1% + Benzoyl Peroxide 2.5% | Retinoid cell-turnover acceleration + antibacterial | Purging weeks 2–6; primary evaluation at 12 weeks | Comedonal and inflammatory acne without resistance |
| Clindamycin 1% + Benzoyl Peroxide 5% | Targeted antimicrobial combination (capped 12 weeks) | Rapid inflammatory lesion reduction in 2–4 weeks | Acute inflammatory acne flare-ups |
Side effects and when to stop
Topical azelaic acid is generally well-tolerated compared to aggressive retinoids or benzoyl peroxide monotherapies. However, localised cutaneous reactions can occur during initial application weeks.
- Common mild reactions: Transient stinging, mild burning, itching, or local dryness usually resolve after 1 to 2 weeks of regular use.
- Application advice: Applying the gel to thoroughly dry skin or buffering with a basic moisturiser decreases initial tingling.
- When to discontinue: Stop treatment and seek medical attention if you experience severe erythema, blistering, facial swelling, or signs of an allergic contact dermatitis.
Why Hi-Doctor vs. walking into a clinic
Navigating private healthcare appointments in Madrid can involve multi-week delays and unpredictable consultation fees. Hi-Doctor provides a structured, fully auditable digital pathway built strictly under Spanish private medical prescription regulations.

Consultations are 100% online with no travel, appointments, or video calls. Your medical file is protected under strict GDPR standards. If the doctor determines that azelaic acid is not clinically suitable or that your case requires in-person hospital evaluation, the 40 EUR consultation fee is refunded in full if the doctor does not issue a prescription.
Spanish REMPE prescriptions carry all mandatory prescriber identifiers under Commission Implementing Directive 2012/52/EU, allowing cross-border pharmacy presentation across the EU under Directive 2011/24/EU.
VEELGESTELDE VRAGEN
Veelgestelde vragen
You can download the REMPE PDF directly from your Hi-Doctor account or email notification. In Madrid and across Spain, you can display the QR code on your mobile device or present a printed copy at any community pharmacy (farmacia), where the pharmacist verifies it against the central electronic repository. Under Directive 2011/24/EU, the PDF can also be presented at any EU pharmacy, where the pharmacist reviews it and may dispense a locally marketed equivalent, though pharmacists retain the right to refuse.





